Eli Lilly and Docplexus invite you for an interactive webinar on 23 rd March 2022 , at 1:00 PM , 4:30 PM , and 10:30 PM GST . In this session, renowned rheumatologists Dr. Raj Sengupta , Prof. Dr. Roberto Caporali , and Prof.
Dr. Philipp Sewerin will discuss “ Spondyloarthritis: Ixekizumab and its Relevance to Clinical Practice. ” Highlights of the session: Efficacy data on ixekizumab for the treatment of spondyloarthritis (active psoriatic arthritis and axial spondyloarthritis) Long-term outcomes and structural progression of spondyloarthritis We invite you to take part and interact with the experts, who will address your queries at the end of the session. Looking forward to your active participation! PP-IX-AE-0681
